Immuron Ltd ADR

Immuron Ltd ADR Current Liabilities

The Current Liabilities of Immuron Ltd ADR (IMRN) as of Nov 3, 2026 is 1.79 M USD. In the previous year, Current Liabilities was 1.67 M USD — a change of 6.81% (higher).

Current Liabilities

1.79 MUSD

YoY

6.81%

Last updated:

Current Liabilities of Immuron Ltd ADR is 2026 1.79 M USD. Current Liabilities of Immuron Ltd ADR was 2025 1.67 M USD. It decreases by 6.81% higher compared to the previous year.

The Immuron Ltd ADR Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
831,722.04 USD
Jan 1, 2020
359,262.60 USD
Jan 1, 2021
780,464.78 USD
Jan 1, 2022
1.05 M USD
Jan 1, 2023
1.06 M USD
Jan 1, 2024
1.88 M USD
Jan 1, 2025
1.67 M USD
Jan 1, 2026
1.79 M USD
The Immuron Ltd ADR Current Liabilities history
YEARCurrent LiabilitiesYoY
1.79 MUSD+6.81%
1.67 MUSD-10.97%
1.88 MUSD+77.45%
1.06 MUSD+1.20%
1.05 MUSD+33.97%
780,464.78USD+117.24%
359,262.60USD-56.80%
831,722.04USD+48.82%
558,876.29USD-52.53%
1.18 MUSD-56.46%
2.70 MUSD+221.82%
840,264.49USD+42.89%
588,068.93USD-31.58%
859,515.70USD+20.10%
715,680.52USD+10.87%
645,488.63USD+114.28%
301,236.97USD-40.08%
502,759.65USD-18.28%
615,248.26USD-32.58%
912,544.14USD-5.39%
964,566.64USD+27.02%
759,386.72USD+31.25%
578,601.24USD—
0.00USD-100.00%
176,596.00USD-28.75%
247,861.36USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Immuron Ltd ADR Stock analysis

What does Immuron Ltd ADR do? Immuron Ltd ADR is a biopharmaceutical company listed on the US market in 2017, operating from Carlton. The firm engages in the research, development, and commercialization of polyclonal antibodies across Australia, the United States, and Canada. It operates through Research and Development and Hyper-immune Products segments. Immuron offers Travelan, an over-the-counter medicine and dietary supplement for digestive health, and Protectyn, an immune supplement. The company also develops clinical-stage candidates, including Travelan (IMM-124E) and IMM-529 for gastrointestinal conditions, alongside the pre-clinical IMM-986. Additionally, Immuron provides a technology platform and maintains collaborations for therapeutic development. Immuron Ltd ADR is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Immuron Ltd ADR stock

Current Liabilities of Immuron Ltd ADR is 1.79 M USD in 2026.

Current Liabilities of Immuron Ltd ADR changed from 1.67 M USD to 1.79 M USD, representing a 6.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Immuron Ltd ADR since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Immuron Ltd ADR historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Immuron Ltd ADR

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Immuron Ltd ADR